Jun. 14, 2011 (Marketwire Canada) --
VANCOUVER, BRITISH COLUMBIA -- EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) announced today that it has signed a Research & Development Agreement with Kellogg Company to measure the nutritional and commercial benefits of EnWave's nutraREV™ food dehydration technology within a broadly defined product area that includes cereal and cereal bars. The Agreement provides an exclusive period of up to 12 months for Kellogg to test nutraREV™ with an option to license the technology at the end of this period. Further terms of the agreement are confidential.
"EnWave is extremely pleased to be working with Kellogg, one of the most highly regarded companies in the global consumer food products industry," stated Dr. Tim Durance, Chairman & Co-CEO, EnWave. "This agreement marks the fifth multinational company to have signed a testing agreement with EnWave over the past three years, and we see this latest announcement as a significant step in our goal to introduce nutraREV™ as a new standard in global food processing technology."
"Kellogg has been working with EnWave in initial tests of this technology, and we are pleased with the results so far," said Margaret Bath, Vice President, Research, Quality and Technology, Kellogg Company.
EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV) technology. REV is used to dehydrate food, bulk liquids, and pharmaceuticals, and the Company's mission is to establish the technology as a new dehydration standard: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has six REV platforms: commercial-scale nutraREV™ and MIVAP™ are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV™ for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV™ for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV™ and freezeREV™ as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
About Kellogg Company
For more than 100 years, consumers have counted on Kellogg for great-tasting, high-quality and nutritious foods. Kellogg Company, with 2010 sales of more than $12 billion, is the world's leading producer of cereal and a leading producer of convenience foods, including cookies, crackers, toaster pastries, cereal bars, fruit-flavored snacks, frozen waffles and veggie foods. Kellogg Company's beloved brands, which are manufactured in 18 countries and marketed in more than 180 countries, include Kellogg's®, Keebler®, Pop-Tarts®, Eggo®, Cheez-It®, All-Bran®, Mini-Wheats®, Nutri-Grain®, Rice Krispies®, Special K®, Chips Deluxe®,Famous Amos®, Sandies®,Austin®, Club®, Murray®, Kashi®, Bear Naked®, Morningstar Farm®, Gardenburger®and Stretch Island®. For more information on the Kellogg Company, including our corporate responsibility initiatives, visit www.kelloggcompany.com.
Dr. Tim Durance, Chairman & Co-CEO
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
President & Co-CEO
V.P. Corporate Development & Investor Relations